Close

CLDN18.2

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. This gene is upregulated in patients with ulcerative colitis and highly overexpressed in infiltrating ductal adenocarcinomas. PKC/MAPK/AP1 (protein kinase C/mitogenactivated protein kinase/activator protein1) dependent pathway regulates the expression of this gene in gastric cells. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jun 2010]
  • CAR Vector Products

  • AbTCR Vector Products

  • CAR Cell Products

  • CAR Viral Particles

  • TriCAR Vector Products

  • CAR Animal Cells

  • CAR mRNA

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
  • CAR Vector Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
XS-0822-YF2116 Anti-Human CLDN18.2 (XW-276) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-276 Mouse scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2117 Anti-Mouse CLDN18.2 (XW-277) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Mouse XW-277 Rat scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2118 Anti-Human CLDN18.2 (XW-278) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-278 Mouse scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2119 Anti-Human CLDN18.2 (XW-279) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-279 Mouse scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2120 Anti-Human CLDN18.2 (XW-280) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-280 Mouse scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2121 Anti-Mouse CLDN18.2 (XW-281) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Mouse XW-281 Rat scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2122 Anti-Human CLDN18.2 (XW-282) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-282 Mouse scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2123 Anti-Human CLDN18.2 (XW-283) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-283 Humanized scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2124 Anti-Human CLDN18.2 (XW-284) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-284 Humanized scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF2125 Anti-Human CLDN18.2 (XW-285) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-285 Mouse scFv-CD28-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-0822-YF8358 TS-Fluc Anti-Human CLDN18.2 scFv (XW-276) CD28-CD3ζ CAR, pCDCAR1 Human XW-276 Mouse 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8359 TS-Fluc Anti-Mouse CLDN18.2 scFv (XW-277) CD28-CD3ζ CAR, pCDCAR1 Mouse XW-277 Rat 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8360 TS-Fluc Anti-Human CLDN18.2 scFv (XW-278) CD28-CD3ζ CAR, pCDCAR1 Human XW-278 Mouse 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8361 TS-Fluc Anti-Human CLDN18.2 scFv (XW-279) CD28-CD3ζ CAR, pCDCAR1 Human XW-279 Mouse 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8362 TS-Fluc Anti-Human CLDN18.2 scFv (XW-280) CD28-CD3ζ CAR, pCDCAR1 Human XW-280 Mouse 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8363 TS-Fluc Anti-Mouse CLDN18.2 scFv (XW-281) CD28-CD3ζ CAR, pCDCAR1 Mouse XW-281 Rat 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8364 TS-Fluc Anti-Human CLDN18.2 scFv (XW-282) CD28-CD3ζ CAR, pCDCAR1 Human XW-282 Mouse 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8365 TS-Fluc Anti-Human CLDN18.2 scFv (XW-283) CD28-CD3ζ CAR, pCDCAR1 Human XW-283 Humanized 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8366 TS-Fluc Anti-Human CLDN18.2 scFv (XW-284) CD28-CD3ζ CAR, pCDCAR1 Human XW-284 Humanized 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0822-YF8367 TS-Fluc Anti-Human CLDN18.2 scFv (XW-285) CD28-CD3ζ CAR, pCDCAR1 Human XW-285 Mouse 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ Lentiviral vector   Add to Cart   Datasheet
XS-0823-LX29 Anti-hCLDN18.2 (182511) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector Human 182511 Adenoviral vectors   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.